Last reviewed · How we verify

Multimodal Pain Regimen

University of California, Los Angeles · FDA-approved active Small molecule

A multimodal pain regimen combines multiple analgesic agents with different mechanisms of action to provide synergistic pain relief.

A multimodal pain regimen combines multiple analgesic agents with different mechanisms of action to provide synergistic pain relief. Used for Acute postoperative pain, Chronic pain conditions.

At a glance

Generic nameMultimodal Pain Regimen
SponsorUniversity of California, Los Angeles
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

This approach typically integrates medications from different drug classes (e.g., opioids, non-steroidal anti-inflammatory drugs, adjuvant analgesics, and/or regional anesthesia techniques) to target pain through multiple pathways simultaneously. By addressing nociceptive, neuropathic, and inflammatory components of pain concurrently, multimodal regimens aim to improve efficacy while potentially reducing individual drug doses and associated adverse effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: